Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedCentrus is a regenerative medicine company that provides point-of-care autologous biologic solutions to healthcare providers. The company specializes in the processing and application of Platelet-Rich Plasma (PRP) and Bone Marrow Aspirate Concentrate (BMAC) for use in orthopedics, sports medicine, and wound care. MedCentrus offers a comprehensive suite of services, including proprietary processing technology, clinical support, and evidence-based treatment protocols. By focusing on the body's natural healing mechanisms, the company aims to improve patient outcomes for chronic musculoskeletal conditions and complex wounds. Their business model integrates advanced medical devices with specialized clinical expertise to facilitate the delivery of orthobiologic therapies in a clinical setting. The company is headquartered in Alpharetta, Georgia, and serves a wide network of clinical partners across the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedCentrus.